Skip to main content
Premium Trial:

Request an Annual Quote

Roche's Termination of Epigenomics Alliance Topped Most-Read GenomeWeb News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Dec. 15.
1. Roche Abandons Biomarker-Development Alliance With Epigenomics (from Dec. 15)
2. White House to Consider NIH Bill That Would Reform Budget, Spending, Oversight, and Growth (Dec. 12)
3. Seeing Market Shift, Invitrogen to Exclusively Distribute Blue Heron's Synthetic Gene Products (Dec. 12)
4. New Company in London Will Help Forge Alliances Between Genomic Industry, Academia (Dec. 13)
5. IntegraGen Opens Subsidiary in US; Former Roche Exec Will Be CEO (Dec. 14)
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.